Australia Stock Exchange release from NEUROSCIENTIFIC : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from NEUROSCIENTIFIC NSB.AX : Quarterly Activities/Appendix 4C Cash Flow Report
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO